Ortho-Clinical Diagnostics, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Ortho-Clinical Diagnostics, Inc. - overview
Established
1939
Location
Raritan, NJ, US
Primary Industry
Medical Devices & Equipment
About
Founded in 1939 and based in New Jersey, US, Ortho-Clinical Diagnostics, Inc. (Ortho) develops and markets diagnostic tools, including Vitros instrumentation systems that use clinical chemistry and immunoassay technologies to diagnose a range of maladies such as cancer, heart disease, and infectious diseases. The company was initially formed as a division of Johnson & Johnson and it was known as Ortho Products, Inc. In 2014, The Carlyle Group acquired Ortho Clinical Diagnostics from Johnson & Johnson for USD 4.
15 billion. As of 2020, Ortho has approximately 4700 employees and a commercial presence in more than 130 countries. In January 2021, Ortho Clinical Diagnostics began trading on the Nasdaq, under the ticker symbol OCDX. The company provides VITROS® automated instruments, assays, reagents used by blood banks and hospitals to screen blood donations for disease and contaminants as well as blood testing systems with reliable ID-Micro Typing Systems; information management, and interpretation tools to clinical laboratories enabling healthcare professionals to make better-informed treatment decisions.
Ortho-Clinical Diagnostics' solutions also include Vitros COVID-19 testing solutions, informatics solutions, and next-generation in clinical chemistry solutions. Additionally, its Immunohematology testing portfolio includes blood type and antibody screen, antibody identification, titration studies, and reflex testing. For the company's fiscal year 2020, which ended in January 2021, Ortho-Clinical Diagnostics generated revenue of USD 1. 77 billion.
Current Investors
Carlyle Group
Primary Industry
Medical Devices & Equipment
Sub Industries
Diagnostic, Medical & Imaging Laboratories, Diagnostic Equipment, Medical Software
Website
www.orthoclinicaldiagnostics.com
Verticals
Manufacturing
Company Stage
Mature
Total Amount Raised
Subscriber access only
Ortho-Clinical Diagnostics, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Completed | Ortho-Clinical Diagnostics, Inc. | - | ||||||||
| Private Placement/Follow on | Completed | Ortho-Clinical Diagnostics, Inc. | - | ||||||||
| IPO | Completed | Ortho-Clinical Diagnostics, Inc. | - | ||||||||
| Buyout | Completed | Ortho-Clinical Diagnostics, Inc. | - | ||||||||
| Buyout | Completed | Therakos, Inc. | - |
Displaying 1 - 5 of 5
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.